ORIGINAL PAPER
Relationship between multimorbidity and sociodemographic factors, depressive symptoms, and lifestyle in middle-aged adults
1
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Submission date: 2023-05-09
Final revision date: 2023-05-28
Acceptance date: 2023-05-30
Publication date: 2023-06-30
Medical Studies 2023;39(2):182-191
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Multimorbidity (MM) is associated with high mortality, disability, more frequent use of both inpatient and outpatient care, lower quality of life, and increased psychological distress and polypharmacy. As a result, MM has recently been recognized as one of the most difficult challenges faced by the global healthcare system. Consequently, identifying the factors that accompany MM may be key for the improvement of overall health in every population, and for the provision of appropriate medical care to patients.
Aim of the research:
To assess the prevalence of MM and the associated factors in middle-aged adults.
Material and methods:
The research material consisted of 12,113 persons aged from 40 to 64 years. The backward stepwise regression method was used to identify factors associated with MM. Sociodemographic data and information about depressive symptoms and lifestyle were analysed.
Results:
A higher likelihood of MM was observed in older individuals of both genders (p < 0.001) who declared more problems related to mental health (p < 0.001), took painkillers regularly, were former smokers, drank less alcohol, and declared abnormal sleeping time (both too short and too long). In addition, MM was associated with a longer sitting time in men and shorter vigorous physical activity in women.
Conclusions:
MM is a frequent problem in adults aged between 40 and 64 years, which necessitates the development of a strategy for the prevention and treatment of MM in middle-aged adults. The complexity of factors related to MM indicates a need to ensure that such patients receive coordinated care from multidisciplinary teams.
Multimorbidity (MM) is associated with high mortality, disability, more frequent use of both inpatient and outpatient care, lower quality of life, and increased psychological distress and polypharmacy. As a result, MM has recently been recognized as one of the most difficult challenges faced by the global healthcare system. Consequently, identifying the factors that accompany MM may be key for the improvement of overall health in every population, and for the provision of appropriate medical care to patients.
Aim of the research:
To assess the prevalence of MM and the associated factors in middle-aged adults.
Material and methods:
The research material consisted of 12,113 persons aged from 40 to 64 years. The backward stepwise regression method was used to identify factors associated with MM. Sociodemographic data and information about depressive symptoms and lifestyle were analysed.
Results:
A higher likelihood of MM was observed in older individuals of both genders (p < 0.001) who declared more problems related to mental health (p < 0.001), took painkillers regularly, were former smokers, drank less alcohol, and declared abnormal sleeping time (both too short and too long). In addition, MM was associated with a longer sitting time in men and shorter vigorous physical activity in women.
Conclusions:
MM is a frequent problem in adults aged between 40 and 64 years, which necessitates the development of a strategy for the prevention and treatment of MM in middle-aged adults. The complexity of factors related to MM indicates a need to ensure that such patients receive coordinated care from multidisciplinary teams.
REFERENCES (42)
1.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37-43.
2.
Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina AM. Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb 2019; 9: 2235042X19870934.
3.
Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine 2023; 57: 101860.
4.
Jovic D, Vukovic D, Marinkovic J. Prevalence and patterns of multi-morbidity in serbian adults: a cross-sectional study. PLoS One 2016; 11: e0148646.
5.
De Carvalho JN, Roncalli ÂG, Cancela MC, Souza DL. Prevalence of multimorbidity in the Brazilian adult population according to socioeconomic and demographic characteristics. PLoS One 2017; 12: e0174322.
6.
Williams JS, Egede LE. The Association between multimorbidity and quality of life, health status and functional disability. Am J Med Sci 2016; 352: 45-52.
7.
Nunes BP, Chiavegatto Filho ADP, Pati S, Cruz Teixeira DS, Flores TR, Camargo-Figuera FA, Munhoz TN, Thumé E, Facchini LA, Rodrigues Batista SR. Contextual and individual inequalities of multimorbidity in Brazilian adults: a cross-sectional national-based study. BMJ Open 2017; 7: e015885.
8.
Singh K, Alomari A, Lenjawi B. Prevalence of multimorbidity in the Middle East: a systematic review of observational studies. Int J Environ Res Public Health 2022; 19: 16502.
9.
Arokiasamy P, Uttamacharya U, Jain K, Biritwum RB, Yawson AE, Wu F, Guo Y, Maximova T, Espinoza BM, Rodríguez AS, Afshar S, Pati S, Ice G, Banerjee S, Liebert MA, Snodgrass JJ, Naidoo N, Chatterji S, Kowal P. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med 2015; 13: 178.
10.
Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS, Brueckle MS, Cesari M, Tinetti ME, Valderas JM. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med 2019; 285: 272-288.
11.
Pearson-Stuttard J, Ezzati M, Gregg EW. Multimorbidity – a defining challenge for health systems. Lancet Public Health 2019; 4: e599-e600.
12.
Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, Lara E, Koskinen S, Tobiasz-Adamczyk B, Ayuso-Mateos JL, Haro JM. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci 2016; 71: 205-214.
13.
Piotrowicz K, Pac A, Skalska A, Mossakowska M, Chudek J, Zdrojewski T, Więcek A, Grodzicki T, Gąsowski J. Patterns of multimorbidity in 4588 older adults: implications for a nongeriatrician specialist. Pol Arch Intern Med 2021; 131: 16128.
14.
Szychowska A, Zimny-Zając A, Dziankowska-Zaborszczyk E, Grodzicki T, Drygas W, Zdrojewski T. Physical activity versus selected health behaviors, subjective physical and psychological health and multimorbidity in a Large Cohort of Polish Seniors during the COVID-19 pandemic (results of the National Test for Poles’ Health). Int J Environ Res Public Health 2022; 20: 556.
15.
Zatonski WA, Manczuk M. Kielce POlish-Norwegian Study (PONS): research on chronic non-communicable diseases in European high risk countries – study design. Ann Agric Environ Med 2011; 18: 203-206.
16.
Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S. Dietary patterns in relation to metabolic syndrome among adults in Poland: a cross-sectional study. Nutrients 2017; 9: 1366.
17.
Koon T, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal infl uences on chronic noncommunicable diseases in low-, middle-, and high income countries. Am Heart J 2009; 158: 1-7.
18.
MacRae C, Mercer SW, Henderson D, McMinn M, Morales DR, Jefferson E, Lyons RA, Lyons J, Dibben C, McAllister DA, Guthrie B. Age, sex, and socioeconomic differences in multimorbidity measured in four ways: UK primary care cross-sectional analysis. Br J Gen Pract 2023; 73: e249-e256.
19.
Xiao X, Beach J, Senthilselvan A. Mortality among Canadian population with multimorbidity: a retrospective cohort study. J Multimorb Comorb 2023; 13: 26335565231157626.
20.
Rzewuska M, de Azevedo-Marques JM, Coxon D, Zanetti ML, Zanetti AC, Franco LJ, Santos JL. Epidemiology of multimorbidity within the Brazilian adult general population: evidence from the 2013 National Health Survey (PNS 2013). PLoS One 2017; 12: e0171813.
21.
Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miran- da JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Primers 2022; 8: 48.
22.
Stagg AL, Hatch S, Fear NT, Dorrington S, Madan I, Stevelink SAM. Long-term health conditions in UK working-age adults: a cross-sectional analysis of associations with demographic, socioeconomic, psychosocial and health-related factors in an inner-city population. BMJ Open 2022; 12: e062115.
23.
Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, Kaur M, Khatib R, Kruger IM, Lamelas P, Lanas F, Lear SA, Li W, Wang C, Quiang D, Wang Y, Lopez-Jaramillo P, Mohammadifard N, Mohan V, Mony PK, Poirier P, Srilatha S, Szuba A, Teo K, Wielgosz A, Yeates KE, Yusoff K, Yusuf R, Yusufali AH, Attaei MW, McKee M, Yusuf S. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health 2019; 7: e748-e760.
24.
Momen NC, Plana-Ripoll O, Agerbo E, Benros ME, Borglum AD, Christensen MK. Association between mental disorders and subsequent medical conditions. N Engl J Med 2020; 382: 1721-1731.
25.
Ronaldson A, Arias de la Torre J, Prina M, Armstrong D, Das-Munshi J, Hatch S, Stewart R, Hotopf M, Dregan A. Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: a prospective analysis using data from the UK Biobank. Lancet Reg Health Eur 2021; 8: 100149.
26.
Triolo F, Harber-Aschan L, Belvederi Murri M, Calderón-Larrañaga A, Vetrano DL, Sjöberg L, Marengoni A, Dekhtyar S. The complex interplay between depression and multimorbidity in late life: risks and pathways. Mech Ageing Dev 2020; 192: 111383.
27.
Pengpid S, Peltzer K, Anantanasuwong D. Bidirectional association between probable depression and multimorbidity among middle-aged and older adults in Thailand. J Multidiscip Healthc 2023; 16: 11-19.
28.
Triolo F, Sjöberg L, Calderón-Larrañaga A, Belvederi Murri M, Vetrano DL, Fratiglioni L, Dekhtyar S. Late-life depression and multimorbidity trajectories: the role of symptom complexity and severity. Age Ageing 2023; 52: afac315.
29.
Ng R, Sutradhar R, Yao Z, Wodchis WP, Rosella LC. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease. Int J Epidemiol 2020; 49: 113-130.
30.
Suliga E, Głuszek-Osuch M, Głuszek S. Prevalence and factors related to the metabolically obese normalweight (MONW) phenotype: a review. Medical Studies 2023; 39: 73-90.
31.
Fortin M, Haggerty J, Almirall J, Bouhali T, Sasseville M, Lemieux M. Lifestyle factors and multimorbidity: a cross sectional study. BMC Public Health 2014; 14: 686.
32.
Poussin C, van der Toorn M, Scheuner S, Piault R, Kondylis A, Savioz R, Dulize R, Peric D, Guedj E, Maranzano F, Merg C, Morelli M, Egesipe AL, Johne S, Majeed S, Pak C, Schneider T, Schlage WK, Ivanov NV, Peitsch MC, Hoeng J. Systems toxicology study reveals reduced impact of heated tobacco product aerosol extract relative to cigarette smoke on premature aging and exacerbation effects in aged aortic cells in vitro. Arch Toxicol 2021; 95: 3341-3359.
33.
Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S, Bell S, Astle W, Stevens D, Koulman A, Selmer RM, Verschuren WMM, Sato S, Njølstad I, Woodward M, Salomaa V, Nordestgaard BG, Yeap BB, Fletcher A, Melander O, Kuller LH, Balkau B, Marmot M, Koenig W, Casiglia E, Cooper C, Arndt V, Franco OH, Wennberg P, Gallacher J, Gómez de la Cámara A, Völzke H, Dahm CC, Dale CE, Bergmann MM, Crespo CJ, van der Schouw YT, Kaaks R, Simons LA, Lagiou P, Schoufour JD, Boer JMA, Key TJ, Rodriguez B, Moreno-Iribas C, Davidson KW, Taylor JO, Sacerdote C, Wallace RB, Quiros JR, Tumi- no R, Blazer 2nd DG, Linneberg A, Daimon M, Panico S, Howard B, Skeie G, Strandberg T, Weiderpass E, Nie- tert PJ, Psaty BM, Kromhout D, Salamanca-Fernandez E, Kiechl S, Krumholz HM, Grioni S, Palli D, Huerta JM, Price J, Sundström J, Arriola L, Arima H, Travis RC, Panagiotakos DB, Karakatsani A, Trichopoulou A, Kühn T, Grobbee DE, Barrett-Connor E, van Schoor N, Boeing H, Overvad K, Kauhanen J, Wareham N, Langenberg C, Forouhi N, Wennberg M, Després JP, Cushman M, Coo- per JA, Rodriguez CJ, Sakurai M, Shaw JE, Knuiman M, Voortman T, Meisinger C, Tjønneland A, Brenner H, Palmieri L, Dallongeville J, Brunner EJ, Assmann G, Trevisan M, Gillum RF, Ford I, Sattar N, Lazo M, Thompson SG, Ferra- ri P, Leon DA, Smith GD, Peto R, Jackson R, Banks E, Di Angelantonio E, Danesh J; Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018; 391: 1513-1523.
34.
Suliga E, Kozieł D, Ciesla E, Rebak D, Głuszek-Osuch M, Naszydłowska E, Głuszek S. The consumption of alcoholic beverages and the prevalence of cardiovascular diseases in men and women: a cross-sectional study. Nutrients 2019; 11: 1318.
35.
Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, Kivimäki M. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: a cohort study. PLoS Med 2018; 15: e1002571.
36.
Han BH, Moore AA, Sherman SE, Palamar JJ. Prevalence and correlates of binge drinking among older adults with multimorbidity. Drug Alcohol Depend 2018; 187: 48-54.
37.
Vancampfort D, Koyanagi A, Ward PB, Rosenbaum S, Schuch FB, Mugisha J, Richards J, Firth J, Stubbs B. Chronic physical conditions, multimorbidity and physical activity across 46 low- and middle-income countries. Int J Behav Nutr Phys Act 2017; 14: 6.
38.
Behera S, Pradhan J. A combination of moderate and vigorous physical activities reduces the burden of multimorbidity: findings from Longitudinal Ageing Study in India. J Health Popul Nutr 2022; 41: 42.
39.
Loprinzi PD, Addoh O, Joyner C. Multimorbidity, mortality, and physical activity. Chronic Illness 2016; 12: 272-280.
40.
Poses-Ferrer E, Parisi R, Gonzalez-Viana A, Castell C, Arias de la Torre J, Jones A, Serra-Sutton V, Espallargues M, Cabezas C. Daily sitting time and its association with non-communicable diseases and multimorbidity in Catalonia. Eur J Public Health 2022; 32: 105-111.
41.
He L, Biddle SJH, Lee JT, Duolikun N, Zhang L, Wang Z, Zhao Y. The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China. Int J Behav Nutr Phys Act 2021; 18: 77.
42.
Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S. Sleep duration and the risk of metabolic syndrome – a cross-sectional study. Medical Studies 2017; 33: 169-175.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
